ISoP 2017:  Pharmacovigilance in the 21st Century – Innovation for Patient Benefit

*Draft programme, may be subject to change

Register Now

Sunday 15th October 2017 Pre-conference courses

Coordinated by Dr Marco Tuccori

Course 1: Pharmacovigilance and social media

Course 2: Paediatric pharmacovigilance

DAY 1: Monday 16th October 2017
09:00 Opening Ceremony
09.30 Keynote Lecture: On the importance of quantifying and propagating uncertainty in healthcare

Speaker: Mark Girolami, Imperial College London, UK

10.30 Coffee and Poster Viewing
11.00 Big data approaches in pharmacovigilance
Munir Pirmohamed, University of Liverpool, UK11.00 – 11.45

Jeremy Rassen, Aetion, USA11.45 – 12.00

Oral Abstract (46)
Identifying chemical substructures associated with adverse drug reactions using deep learning framework
Speaker: Sanjoy Dey, IBM T. J. Watson Research Center, USA

12.00 Social media and pharmacovigilance: an industry perspective
Chair: Sten Olsson, President of ISoP, Sweden 

12.00 – 12.45
Speaker: David Lewis, Novartis, Switzerland

12.45 – 13.00
Oral Abstract (74)
Beyond co-occurence-based ADR detection from social media
Speaker: Danushka Bollegala, University of Liverpool, UK

13.00 Lunch and Poster Viewing
14.00 Regulation in the 21st Century: Round Table Discussion

Chair: Mick Foy

Sabine Brosch, EMA, UK
Judith Zander, FDA, USA
Shanthi, Pal, WHO, Switzerland
Alex Dodoo, WHO, Ghana
Michael Dougan, University of Liverpool, UK

15.00 ISoP Chapter session
Chair: Brian Edwards, NDA Regulatory Consulting,
ISoP SIG session
Chair: Deirdre McCarthy, Quintiles, USA 
16.00 Coffee and Poster Viewing
16.30 PARALLEL SESSION A. Training in Pharmacovigilance
Chairs: Andrew Bate, Pfizer, UK and Hilda Ampadu, The African Collaborating Center for PV, WHO Collaborating Centre for Advocacy & Training in Pharmacovigilance, Ghana16.30 – 17.00

Training in pharmacovigilance in Africa
Speaker Alex Dodoo, WHO, Ghana17.00 – 17.30

Experience of running a Masters level course
Speaker: Sherael Webley, University of Herts, UK17.30 – 17.45
Oral Abstract (131)

ISoP Global standard for career framework in pharmacovigilance – special interest group status report
Speaker: Jan Petracek, European Pharminvent Services, Czech Republic17.45 – 18.00
Oral Abstract (33)
Pharmacovigilance and rational drug use content in pharmacology education in medical schools in Turkey
Speaker: Muberra Güner, Tobb Economy & Technology University Faculty of Medicine Department of Medical Pharmacology, Turkey

PARALLEL SESSION B. Pharmacogenomics and Pharmacovigilance
Chair: Ana Alfirevic, University of Liverpool, UK 

16.30 – 17.00
Genetics and prevention of serious cutaneous adverse drug reactions
Speaker: Chonlapat Sukasem, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand

17.00 – 17.30
Pre-emptive genotyping for preventing ADRs
Speaker: Henk-Jan Guchelaar, Leiden University Medical Centre, The Netherlands

17.30 – 18.00
Precision dosing to reduce ADRs in children
Speaker: Dan Hawcutt, University of Liverpool, UK

18.00 – 18.15
Oral Abstract (238)
Whole exome sequencing in individuals with stain-induced myopathy
Speaker: Kate Bloch, University of Liverpool, UK

19:30 Conference Gala Dinner
DAY 2: Tuesday 17th October 2017
09.00 CIOMS Lecture
Chair: Herve Le Louet, Henri Mondor University Hospital, France

The new CIOMS
Speaker: Lembit Rägo, Council for International Organizations of Medical Sciences (CIOMS), Switzerland 

10.00 Pharmacovigilance for herbal and traditional medicines: towards solutions and innovations
Chair: Joanne Barnes, University of Auckland, New ZealandSpeaker: Phil Routledge, University of Cardiff, UK
10.45 Coffee and Poster Viewing
11.15 Phenotypic approaches to risk management
Chairs: Raul Andrade, University of Malaga, Spain and Chia Yu Chu, International Medical Service Center, Department of Dermatology, National Taiwan University Hospital, Taiwan11.15 – 11.45
Clinical assessment for risk management: a general overview
Speaker Kin-Wei Chan, University of Harvard, USA

11.45 – 12.15
Serious cutaneous adverse drug reactions
Speaker: Maja Mockenhauput, Freiburg, Germany 

12.15 Phenotypic approaches to risk management (continued)

12.15 – 12.45
Drug-induced liver injury
Speaker: Guru Aithal, University of Nottingham, UK

12.45 – 13.00
Oral Abstract (36)
Drug-induced bone loss: A study of the French and Spanish pharamcovigilance databases
Speaker: Haleh Bagheri, Service De Pharmacologie Médicale Et Clinique, Centre De Pharmacovigilance, France


13.00 Lunch and Poster Viewing
14.00 Poster viewing
15.00 ISoP General Assembly


16.00 Coffee and Poster Viewing
16.30 PARALLEL SESSION C. Medicines for women
Chair: Mira Harrison-Woolrych, University of Otago, New Zealand16.30 – 17.00
Medicines in pregnancy
Speaker: Laura Yates, UK Teratology Information Service (UKTIS) – Newcastle upon Tyne, UK

17.00 – 17.30
Safety of HRTs and OCs
Speaker: Valerie Beral, University of Oxford, UK

17.30 – 17.45
Oral Abstract (26)
Gender differences in reported adverse drug reactions of SSRIs
Speaker: Florence van Hunsel, Netherlands Pharmacovigilance Centre Lareb’s Hertogenbosch, the Netherlands

17.45 – 18.00
Oral Abstract (86)
Ladies’ territory? Patient sex distribution in a global database of suspected adverse drug reactions
Speaker: Sarah Watson, WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Sweden

PARALLEL SESSION D. Implications of WEB-RADR for pharmacovigilance
Chair: Phil Tregunno, MHRA, UK16.30 – 17.00
Needles in hay-use of machine learning to identify references to drugs and adverse events in social media
Speaker: Niklas Noren, Uppsala Monitoring Centre, Sweden

17.00 – 17.30
Where is social media able to make a positive contribution to pharmacovigilance?
Speaker: Simon Maskell, University of Liverpool, UK

17.30 – 18.00
Regulatory implications of WEB-RADR finding
Speaker: Sabine Brosch, EMA, UK

18.00 – 18.15
Oral Abstract (48)
The WEB-RADR project: Characteristics and quality of ADR reports submitted through new reporting tools
Speaker: Linda Härmark, Netherlands Pharmacovigilance Centre Lareb’s-Hertogenbosch, The Netherlands

18:15 Conference Reception
DAY 3: Wednesday 18th October 2017
09.00 Bengt Erik Wiholm Lecture / ISoP Lecture
Chair: Sten Olsson, President of ISoPThe language of pharmacovigilance
Speaker: Jeff Aronson, University of Oxford, UK
10.00 Adverse effects of advanced cell therapies
Chair: Luis Alesso, Cordoba National University, ArgentinaSpeaker: Brigitte Keller-Stanislawski, Paul-Ehrlich Institute, Germany
10.50 Coffee and Poster Viewing
11.20 Pharmacovigilance of biologics and biosimilars
Chair: Jayesh Pandit, Bayer Healthcare, KenyaSpeaker: Gianluca Trifirò, University of Messina, Italy
12.10 Pharmacovigilance of anti-cancer medicines: opportunities and challenges

Chair: Herve Le Louet, Henri Mondor University Hospital, France

Speaker: Anna Olsson-Brown, University of Liverpool, UK

13.00 Closing ceremony, Poster Prize Awards & Presentation for ISoP 2018
13.15 Light Lunch








Conference Partners
Peter House,
Manchester M1 5AN
United Kingdom
Phone:+44 161 209 3354